A deep-learning based artificial intelligence (AI) approach for differentiation of clear cell renal cell carcinoma from oncocytoma on multi-phasic MRI
Clinical Imaging Jun 21, 2021
Nikpanah M, Xu Z, Jin D, et al. - In this study, the diagnostic performance of a deep convolutional neural network for differentiation of clear cell renal cell carcinoma (ccRCC) from renal oncocytoma was explored. Researchers designed a retrospective study including a total of 74 patients (49 male, mean age 59.3) with 243 renal masses (203 ccRCC and 40 oncocytoma) that underwent MR imaging 6 months prior to pathologic confirmation of the lesions. In this study, the developed AI system demonstrated high diagnostic performance in differentiation of ccRCC vs oncocytoma on multi-phasic MRIs.
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries